CWG
ALXN

C WorldWide Group’s Alexion Pharmaceuticals ALXN Stock Holding History

C WorldWide Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-47,325
Closed -$6.4M – 116
2019
Q1 		$6.4M Sell
47,325
-4,275
-8% -$532K 0.08% 48
2018
Q4 		$5.02M Sell
51,600
-14,247
-22% -$1.68M 0.07% 48
2018
Q3 		$9.15M Sell
65,847
-9,727
-13% -$1.22M 0.12% 44
2018
Q2 		$9.38M Hold
75,574
– – 0.13% 42
2018
Q1 		$8.42M Sell
75,574
-130
-0.2% -$15.5K 0.13% 43
2017
Q4 		$9.05M Sell
75,704
-6,240
-8% -$760K 0.13% 49
2017
Q3 		$11.5M Sell
81,944
-31,483
-28% -$4.28M 0.16% 40
2017
Q2 		$13.8M Buy
113,427
+74,676
+193% +$8.69M 0.21% 38
2017
Q1 		$4.7M Buy
38,751
+87
+0.2% +$11.2K 0.08% 56
2016
Q4 		$4.73M Sell
38,664
-5,897
-13% -$722K 0.09% 57
2016
Q3 		$5.46M Buy
44,561
+2,600
+6% +$335K 0.1% 49
2016
Q2 		$4.9M Buy
41,961
+400
+1% +$56.8K 0.09% 48
2016
Q1 		$5.79M Buy
41,561
+350
+0.8% +$51.4K 0.11% 46
2015
Q4 		$7.86M Hold
41,211
– – 0.14% 47
2015
Q3 		$6.45M Sell
41,211
-850
-2% -$155K 0.11% 48
2015
Q2 		$7.6M Sell
42,061
-4,600
-10% -$794K 0.11% 50
2015
Q1 		$8.09M Hold
46,661
– – 0.12% 46
2014
Q4 		$8.63M Sell
46,661
-38,969
-46% -$7.22M 0.13% 41
2014
Q3 		$14.2M Buy
+85,630
New +$14.1M 0.21% 37

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

C WorldWide Group's ALXN Position: Q2 2019 in Review

C WorldWide Group sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 47,325 shares — an estimated $6.4M sold.

C WorldWide Group first reported a position in ALXN in Q3 2014 and held it in 19 quarters. The position peaked at $14.2M in Q3 2014. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

  • C WorldWide Group reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 47,325 Alexion Pharmaceuticals shares in Q2 2019, an estimated $6.4M.
  • C WorldWide Group first reported a position in Alexion Pharmaceuticals in Q3 2014 and held it in 19 quarters.
  • C WorldWide Group's Alexion Pharmaceuticals position peaked at $14.2M in Q3 2014.
  • 636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.